| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 ATRX DYNC2H1 NVL CHD7 DDX55 ATP8B2 DHX30 MDN1 SMARCA4 KIF28P ATP4A MOV10 ATP5F1B AFG1L | 2.11e-07 | 441 | 131 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 ATRX DYNC2H1 NVL CHD7 DDX55 KIF24 ATP8B2 DHX30 MDN1 SMARCA2 SMARCA4 KIF28P ATP4A MOV10 ATP5F1B AFG1L | 5.70e-07 | 614 | 131 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | dihydrosphingosine-1-phosphate phosphatase activity | 4.27e-05 | 2 | 131 | 2 | GO:0070780 | |
| GeneOntologyMolecularFunction | helicase activity | 8.35e-05 | 158 | 131 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ATRX GARS1 CHD7 DDX55 DHX30 CRY2 TRMU METTL1 SMARCA2 EXO1 SMARCA4 METTL2A METTL2B MOV10 | 8.83e-05 | 645 | 131 | 14 | GO:0140640 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.88e-05 | 37 | 131 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA1 ATRX DYNC2H1 GARS1 NVL CHD7 DDX55 ATP8B2 DHX30 MDN1 SMARCA4 KIF28P ATP4A MOV10 ATP5F1B AFG1L | 1.24e-04 | 839 | 131 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA1 ATRX DYNC2H1 GARS1 NVL CHD7 DDX55 ATP8B2 DHX30 MDN1 SMARCA4 KIF28P ATP4A MOV10 ATP5F1B AFG1L | 1.25e-04 | 840 | 131 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA1 ATRX DYNC2H1 GARS1 NVL CHD7 DDX55 ATP8B2 DHX30 MDN1 SMARCA4 KIF28P ATP4A MOV10 ATP5F1B AFG1L | 1.25e-04 | 840 | 131 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA1 ATRX DYNC2H1 NVL CHD7 DDX55 ATP8B2 DHX30 MDN1 SMARCA4 KIF28P ATP4A MOV10 ATP5F1B AFG1L | 1.74e-04 | 775 | 131 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | tRNA (cytidine-3-)-methyltransferase activity | 2.54e-04 | 4 | 131 | 2 | GO:0052735 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 8.26e-04 | 167 | 131 | 6 | GO:0031490 | |
| GeneOntologyMolecularFunction | sphingosine-1-phosphate phosphatase activity | 8.78e-04 | 7 | 131 | 2 | GO:0042392 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 1.17e-03 | 8 | 131 | 2 | GO:0090554 | |
| Domain | BRK | 5.77e-06 | 6 | 125 | 3 | SM00592 | |
| Domain | BRK_domain | 5.77e-06 | 6 | 125 | 3 | IPR006576 | |
| Domain | BRK | 5.77e-06 | 6 | 125 | 3 | PF07533 | |
| Domain | P-loop_NTPase | ABCA1 ATRX DYNC2H1 NVL HS3ST5 GAL3ST4 CHD7 DDX55 KIF24 DHX30 MDN1 MTHFD1 EHD1 SMARCA2 SMARCA4 MOV10 ATP5F1B AFG1L | 1.38e-05 | 848 | 125 | 18 | IPR027417 |
| Domain | - | ABCA1 ATRX DYNC2H1 NVL HS3ST5 CHD7 DDX55 DHX30 MDN1 MTHFD1 EHD1 SMARCA2 SMARCA4 MOV10 ATP5F1B AFG1L | 3.84e-05 | 746 | 125 | 16 | 3.40.50.300 |
| Domain | Gln-Leu-Gln_QLQ | 4.44e-05 | 2 | 125 | 2 | IPR014978 | |
| Domain | SnAC | 4.44e-05 | 2 | 125 | 2 | PF14619 | |
| Domain | QLQ | 4.44e-05 | 2 | 125 | 2 | SM00951 | |
| Domain | QLQ | 4.44e-05 | 2 | 125 | 2 | PS51666 | |
| Domain | SnAC | 4.44e-05 | 2 | 125 | 2 | SM01314 | |
| Domain | SnAC | 4.44e-05 | 2 | 125 | 2 | IPR029295 | |
| Domain | QLQ | 4.44e-05 | 2 | 125 | 2 | PF08880 | |
| Domain | SNF2_N | 5.95e-05 | 32 | 125 | 4 | IPR000330 | |
| Domain | SNF2_N | 5.95e-05 | 32 | 125 | 4 | PF00176 | |
| Domain | Helicase_C | 8.29e-05 | 107 | 125 | 6 | PF00271 | |
| Domain | HELICc | 8.29e-05 | 107 | 125 | 6 | SM00490 | |
| Domain | Helicase_C | 8.73e-05 | 108 | 125 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 9.19e-05 | 109 | 125 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 9.19e-05 | 109 | 125 | 6 | PS51192 | |
| Domain | DEXDc | 9.19e-05 | 109 | 125 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 9.67e-05 | 110 | 125 | 6 | IPR014001 | |
| Domain | HSA | 2.64e-04 | 4 | 125 | 2 | SM00573 | |
| Domain | HSA | 2.64e-04 | 4 | 125 | 2 | PS51204 | |
| Domain | MeTrfase | 2.64e-04 | 4 | 125 | 2 | IPR026113 | |
| Domain | HSA_dom | 2.64e-04 | 4 | 125 | 2 | IPR014012 | |
| Domain | HSA | 2.64e-04 | 4 | 125 | 2 | PF07529 | |
| Domain | Methyltransf_12 | 6.55e-04 | 6 | 125 | 2 | IPR013217 | |
| Domain | Methyltransf_12 | 6.55e-04 | 6 | 125 | 2 | PF08242 | |
| Domain | Peptidase_S54_rhomboid | 1.21e-03 | 8 | 125 | 2 | IPR002610 | |
| Domain | - | 1.28e-03 | 120 | 125 | 5 | 3.40.50.150 | |
| Domain | SAM-dependent_MTases | 1.38e-03 | 122 | 125 | 5 | IPR029063 | |
| Domain | Peptidase_S54_rhomboid_dom | 1.55e-03 | 9 | 125 | 2 | IPR022764 | |
| Domain | Rhomboid | 1.55e-03 | 9 | 125 | 2 | PF01694 | |
| Domain | - | 1.55e-03 | 9 | 125 | 2 | 1.20.1540.10 | |
| Domain | AAA | 2.84e-03 | 144 | 125 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 2.84e-03 | 144 | 125 | 5 | IPR003593 | |
| Domain | EF-hand-dom_pair | 3.21e-03 | 287 | 125 | 7 | IPR011992 | |
| Domain | ATPase_dyneun-rel_AAA | 3.84e-03 | 14 | 125 | 2 | IPR011704 | |
| Domain | AAA_5 | 3.84e-03 | 14 | 125 | 2 | PF07728 | |
| Domain | Histone_H2A_CS | 4.41e-03 | 15 | 125 | 2 | IPR032458 | |
| Domain | EF_HAND_2 | 4.64e-03 | 231 | 125 | 6 | PS50222 | |
| Domain | EF_hand_dom | 4.74e-03 | 232 | 125 | 6 | IPR002048 | |
| Domain | Histone_H2A_C | 5.66e-03 | 17 | 125 | 2 | IPR032454 | |
| Domain | Histone_H2A_C | 5.66e-03 | 17 | 125 | 2 | PF16211 | |
| Domain | - | 6.34e-03 | 18 | 125 | 2 | 1.20.144.10 | |
| Domain | acidPPc | 6.34e-03 | 18 | 125 | 2 | SM00014 | |
| Pubmed | 9.16e-10 | 13 | 132 | 5 | 23319608 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATRX NVL DDX55 DHX30 CEP170 METTL1 SMARCA2 SMARCA4 ARHGEF2 MED23 MOV10 | 1.03e-06 | 440 | 132 | 11 | 34244565 |
| Pubmed | Activation of ATP-binding cassette transporter A1 transcription by chromatin remodeling complex. | 1.06e-06 | 6 | 132 | 3 | 15774904 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRAF2 CAND1 ATRX DYNC2H1 RGS22 GARS1 DDX55 NDUFS1 DHX30 GANAB KIDINS220 MDN1 MTHFD1 EIF2B5 SMARCA4 H2AZ1 PLCG1 MED23 ATP5F1B | 1.94e-06 | 1425 | 132 | 19 | 30948266 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CAND1 H2AZ2 DYNC2H1 GARS1 VPS33A ZZEF1 EPG5 DUOX1 GANAB MDN1 AKAP9 GRHPR MTHFD1 ATP5F1B | 2.57e-06 | 807 | 132 | 14 | 30575818 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDCD2 TRAF2 CAND1 GARS1 CHD7 NDUFS1 DHX30 MDN1 GRHPR MTHFD1 EHD1 EIF2B5 SMARCA2 SMARCA4 PLCG1 ARHGEF2 MOV10 ATP5F1B | 3.84e-06 | 1353 | 132 | 18 | 29467282 |
| Pubmed | CAND1 H2AZ2 ATRX KDM5A CHD7 DDX55 CIT NDUFS1 DHX30 LGALS8 INTS5 KIDINS220 MDN1 MTHFD1 SMARCA2 ARHGEF2 MED23 MOV10 ATP5F1B | 3.97e-06 | 1497 | 132 | 19 | 31527615 | |
| Pubmed | 1.03e-05 | 129 | 132 | 6 | 23022380 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8670841 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23163725 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12411432 | ||
| Pubmed | Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development. | 1.43e-05 | 2 | 132 | 2 | 23076393 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15576411 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15240517 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26564006 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 1.43e-05 | 2 | 132 | 2 | 33027072 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23872584 | ||
| Pubmed | Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma. | 1.43e-05 | 2 | 132 | 2 | 23088494 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 20333683 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 34812766 | ||
| Pubmed | Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy. | 1.43e-05 | 2 | 132 | 2 | 30478150 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 30624618 | ||
| Pubmed | The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation. | 1.43e-05 | 2 | 132 | 2 | 25808524 | |
| Pubmed | Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation. | 1.43e-05 | 2 | 132 | 2 | 19144648 | |
| Pubmed | High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer. | 1.43e-05 | 2 | 132 | 2 | 29391527 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 37634210 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 8208605 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 36335301 | ||
| Pubmed | A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. | 1.43e-05 | 2 | 132 | 2 | 11163203 | |
| Pubmed | Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. | 1.43e-05 | 2 | 132 | 2 | 12620226 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27039070 | ||
| Pubmed | H2A.Z facilitates licensing and activation of early replication origins. | 1.43e-05 | 2 | 132 | 2 | 31875854 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 29848589 | ||
| Pubmed | Histone H2A.Z is required for androgen receptor-mediated effects on fear memory. | 1.43e-05 | 2 | 132 | 2 | 32916283 | |
| Pubmed | Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein. | 1.43e-05 | 2 | 132 | 2 | 9603422 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 25304051 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 23276717 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27097303 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 28038711 | ||
| Pubmed | Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury. | 1.43e-05 | 2 | 132 | 2 | 23963727 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 15837834 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12493776 | ||
| Pubmed | Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4. | 1.43e-05 | 2 | 132 | 2 | 31375262 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 17075831 | ||
| Pubmed | Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma. | 1.43e-05 | 2 | 132 | 2 | 32855269 | |
| Pubmed | Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity. | 1.43e-05 | 2 | 132 | 2 | 22721696 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 18508913 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 11719516 | ||
| Pubmed | H2A.Z is dispensable for both basal and activated transcription in post-mitotic mouse muscles. | 1.43e-05 | 2 | 132 | 2 | 32266374 | |
| Pubmed | DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes. | 1.43e-05 | 2 | 132 | 2 | 28706277 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 21092585 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 27059959 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 22847298 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 32868857 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26551623 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 19458193 | ||
| Pubmed | The replacement histone H2A.Z in a hyperacetylated form is a feature of active genes in the chicken. | 1.43e-05 | 2 | 132 | 2 | 16204459 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 34289068 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 34518526 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 32312722 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 26356327 | ||
| Pubmed | Characterization of the histone H2A.Z-1 and H2A.Z-2 isoforms in vertebrates. | 1.43e-05 | 2 | 132 | 2 | 20003410 | |
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 12566296 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 38366138 | ||
| Pubmed | 1.43e-05 | 2 | 132 | 2 | 31406271 | ||
| Pubmed | Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits. | 1.43e-05 | 2 | 132 | 2 | 29273066 | |
| Pubmed | 2.35e-05 | 15 | 132 | 3 | 19762545 | ||
| Pubmed | 3.15e-05 | 157 | 132 | 6 | 30186101 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CAND1 NVL DDX55 DHX30 CEP170 MDN1 EIF2B5 EXO1 SMARCA4 ARHGEF2 MED23 MOV10 | 3.43e-05 | 759 | 132 | 12 | 35915203 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | H2AZ2 ATRX VPS33A NVL MAP3K5 GANAB MDN1 SMARCA2 SMARCA4 MED23 | 3.86e-05 | 533 | 132 | 10 | 30554943 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATRX KDM5A CHD7 PALB2 INTS5 MDN1 EIF2B5 SMARCA2 EXO1 SMARCA4 ARHGEF2 KAT6B | 4.14e-05 | 774 | 132 | 12 | 15302935 |
| Pubmed | NVL FRYL CHD7 NDUFS1 DHX30 CEP170 GANAB MDN1 SMARCA2 SMARCA4 MOV10 | 4.18e-05 | 653 | 132 | 11 | 22586326 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 18007661 | ||
| Pubmed | DNA damage sensitivity of SWI/SNF-deficient cells depends on TFIIH subunit p62/GTF2H1. | 4.28e-05 | 3 | 132 | 2 | 30287812 | |
| Pubmed | Chromatin context and ncRNA highlight targets of MeCP2 in brain. | 4.28e-05 | 3 | 132 | 2 | 24270455 | |
| Pubmed | ABCA1 Regulates IOP by Modulating Cav1/eNOS/NO Signaling Pathway. | 4.28e-05 | 3 | 132 | 2 | 32428234 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 15248063 | ||
| Pubmed | Expression of candidate cell death genes in cell lines during apoptosis. | 4.28e-05 | 3 | 132 | 2 | 7654317 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 12138164 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 15034933 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 34525369 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 32694618 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 12044884 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 21518954 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 35069435 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 25797626 | ||
| Pubmed | Characterization of mammary tumors from Brg1 heterozygous mice. | 4.28e-05 | 3 | 132 | 2 | 17637742 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 29054927 | ||
| Pubmed | Identification and characterization of the two isoforms of the vertebrate H2A.Z histone variant. | 4.28e-05 | 3 | 132 | 2 | 20299344 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 32427860 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 18480058 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 28292935 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 36464671 | ||
| Pubmed | The H2A.Z histone variant integrates Wnt signaling in intestinal epithelial homeostasis. | 4.28e-05 | 3 | 132 | 2 | 31015444 | |
| Pubmed | Spatiotemporal transcriptome atlas reveals the regional specification of the developing human brain. | 4.28e-05 | 3 | 132 | 2 | 38091994 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 17938176 | ||
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 22740088 | ||
| Pubmed | ASK1 contributes to fibrosis and dysfunction in models of kidney disease. | 4.28e-05 | 3 | 132 | 2 | 30024858 | |
| Pubmed | 4.28e-05 | 3 | 132 | 2 | 15075294 | ||
| Pubmed | Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A. | 4.28e-05 | 3 | 132 | 2 | 25766329 | |
| GeneFamily | Methyltransferase like | 2.29e-05 | 33 | 92 | 4 | 963 | |
| GeneFamily | Sphingosine-1-phosphate phosphatases | 2.56e-05 | 2 | 92 | 2 | 1070 | |
| GeneFamily | EF-hand domain containing | 8.84e-04 | 219 | 92 | 6 | 863 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | MED18 CEBPD KDM5A ITGA10 NDUFS1 MAP3K5 DHX30 GRHPR EIF2B5 SMARCA2 PLCG1 KAT6B DOCK6 | 4.73e-06 | 567 | 129 | 13 | M16909 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TRIB2 H2AZ2 ATRX KDM5A DUSP2 MGAT4A CASP1 FRYL ATP8B2 EPG5 CD84 PTP4A2 ZNF276 KIDINS220 AKAP9 EHD1 SELENOF CRTAM SMARCA2 PLCG1 KAT6B | 1.26e-05 | 1492 | 129 | 21 | M40023 |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | CEBPD H2AZ2 ATRX KDM5A NDUFS1 MAP3K5 TCEAL1 PTP4A2 MTHFD1 SMARCA2 ATP5F1B | 2.70e-05 | 481 | 129 | 11 | M3898 |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 4.62e-05 | 191 | 129 | 7 | M40019 | |
| Coexpression | GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP | 5.99e-05 | 199 | 129 | 7 | M9480 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN | 5.99e-05 | 199 | 129 | 7 | M6157 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN | 6.18e-05 | 200 | 129 | 7 | M6445 | |
| Coexpression | GSE22886_DC_VS_MONOCYTE_DN | 6.18e-05 | 200 | 129 | 7 | M4472 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.03e-07 | 193 | 130 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.11e-07 | 195 | 130 | 8 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-07 | 170 | 130 | 7 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.44e-07 | 175 | 130 | 7 | 901f0181a30e5cc609dcada8d8a59f0468df6fa5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.06e-06 | 200 | 130 | 7 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.06e-06 | 200 | 130 | 7 | a581f1704a87b0390e1e2ff85053367d85247755 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.06e-06 | 200 | 130 | 7 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-06 | 142 | 130 | 6 | c2a3cd9998fd9a8e6b2665347ca5c32511776488 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.91e-06 | 161 | 130 | 6 | 52556b89808e551540f33a13f57417a6696c2438 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.91e-06 | 161 | 130 | 6 | 54f156cf2bd5a6ba9a78ec4e3ee28b89998aec2e | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.91e-06 | 161 | 130 | 6 | 242891be849a4398fe8bea44875ae1ba57950944 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pvalb_(MGE-derived_cortical_interneurons--basket_cells)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.17e-05 | 48 | 130 | 4 | 551be574263b25ef971ed9ea897f44707f1f2bb7 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pvalb_(MGE-derived_cortical_interneurons--basket_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.17e-05 | 48 | 130 | 4 | b4338a4f976425ff055a3dea48b6c1e9d6b49bac | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pvalb_(MGE-derived_cortical_interneurons--basket_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.17e-05 | 48 | 130 | 4 | 1bf16774cec498d4b2b99fcdc5a7a1c3bfec24b8 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 193 | 130 | 6 | 0208fcd8ea4662f40fc2c072ac220d97823eec12 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 193 | 130 | 6 | 04d47ba7cc1f19f1ffb18d9e68469e75063697cf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-05 | 193 | 130 | 6 | fc2eb6a7b4f1e687bf37e59e3cd52b14f99ffea4 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 194 | 130 | 6 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.34e-05 | 195 | 130 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.34e-05 | 195 | 130 | 6 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 195 | 130 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-05 | 195 | 130 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 2.48e-05 | 197 | 130 | 6 | 2b3cd318c988364adcba4441444045914d58fe46 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-BMP_responsible_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.70e-05 | 200 | 130 | 6 | 26251ed8c7fa7e87973d6f59bd398c88ad025395 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.72e-05 | 145 | 130 | 5 | 23a1ee986774725a9f5a9154fbbd023031fb0452 | |
| ToppCell | ASK428-Immune-Mast_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.17e-04 | 163 | 130 | 5 | 569ca0e8ce307f258910b0c75c498009a9651e6e | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 1.17e-04 | 163 | 130 | 5 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 1.20e-04 | 164 | 130 | 5 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 167 | 130 | 5 | 895844a45721988788d01120eb880603ba3ca139 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 167 | 130 | 5 | cde82e3dacf347226a78873b166608b7851b34d4 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 167 | 130 | 5 | 6f54a699d9266c5f09ed890a11b403a6c8476fc1 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Megakaryocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.42e-04 | 170 | 130 | 5 | eace4dd09cdbde0fa40a6aa0f3dba1114d0ce475 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 170 | 130 | 5 | d74fbd995a8a37fc237f7147d398357b811d6452 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 171 | 130 | 5 | f12c2e48637b96557afbc2006a3a23ba21b7951e | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 171 | 130 | 5 | 12c98dea7370377695c5d22309f78ba03e282a0e | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 174 | 130 | 5 | 986e591d3d46009e53548dfa1f2126cf31063ef4 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 174 | 130 | 5 | 785be49a2dbbb1dff0fbced1b48b942c2f4a508d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 175 | 130 | 5 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 175 | 130 | 5 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 176 | 130 | 5 | 9e719e6323597ecfc758c957256872cd4ae24d4d | |
| ToppCell | Dividing_Macrophages-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.76e-04 | 178 | 130 | 5 | 6557688c6790a5bcc3b9aea5b8789cf9506b3c54 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.81e-04 | 179 | 130 | 5 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.81e-04 | 179 | 130 | 5 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-04 | 180 | 130 | 5 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 180 | 130 | 5 | 8cef63866c205df3825df84ce51fa61aa04ae491 | |
| ToppCell | Severe-B_memory-3|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.85e-04 | 180 | 130 | 5 | 90b812c5450359b1745b413421b71e291c97086a | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.90e-04 | 181 | 130 | 5 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.90e-04 | 181 | 130 | 5 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.90e-04 | 181 | 130 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.95e-04 | 182 | 130 | 5 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 182 | 130 | 5 | 2ef6889321fd0104d277518d130e19143b3af41c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 182 | 130 | 5 | 75608f80fd570da499891dc02f8649d5428b896c | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 182 | 130 | 5 | fe4fb213dc0ca482b0f94097fe1b0a51fc2690e2 | |
| ToppCell | 3'_v3-blood-Hematopoietic_Erythro-Mega-Mega-Mast|blood / Manually curated celltypes from each tissue | 1.95e-04 | 182 | 130 | 5 | 1923b5669901f828e890416c22d1f1d21a4a2c6a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-MPO+_mono-neutrophil|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 183 | 130 | 5 | 01c7f01498a9894920edf8243e41187cbdf90688 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-04 | 184 | 130 | 5 | 371c1927ac06b77ff462a94cca6acb802f9724ff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-04 | 184 | 130 | 5 | fbac70333e4f028bfbdd9cc9401427caac9f0c47 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-04 | 184 | 130 | 5 | dd6777a0cb49cd79fc439920c3c930a1e4681bb0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.10e-04 | 185 | 130 | 5 | 6b832b3e080dfadd21253ac45022192f4d3cb37b | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.10e-04 | 185 | 130 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-04 | 185 | 130 | 5 | 2a8104f610fa5ce618f8105521616722462a0d42 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.10e-04 | 185 | 130 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | PBMC-Mild-cDC_8|Mild / Compartment, Disease Groups and Clusters | 2.10e-04 | 185 | 130 | 5 | 891b39c20fe9858fbba90d9ef7a253f1a0870211 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.16e-04 | 186 | 130 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.16e-04 | 186 | 130 | 5 | c7e2134454ab5d0885050dd1bb3c3bd15bf497ac | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.16e-04 | 186 | 130 | 5 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 187 | 130 | 5 | 5ce7cf02990465b6f793205e4be07e8337b3570a | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 187 | 130 | 5 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 187 | 130 | 5 | 17a37fc3a1d62fef3137e5ff26a84c0b8c80e124 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 187 | 130 | 5 | 1b0eb29394040555516677b9de75c15e769c4c53 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-04 | 187 | 130 | 5 | ba822dbceb47257129d6a8c9639c08d76de6d6a3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-04 | 187 | 130 | 5 | 11c773cf3dc1e725b7e4d8edd676c8a94a231d2a | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.27e-04 | 188 | 130 | 5 | c80956649b10b7dd7540394a00fc2a0619b27e80 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 189 | 130 | 5 | 389ccb68acb82893709f256315111470cf4beed3 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.32e-04 | 189 | 130 | 5 | f1129eb122bbc051457c5545f1a267beb988b0f2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 189 | 130 | 5 | 58465b9407fbce91cca8f199950d6e0054c38fbc | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.32e-04 | 189 | 130 | 5 | 0b012ee301419fa9ccc387c3ff66c2344b349a97 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-04 | 189 | 130 | 5 | 7ac78441a15a82218deaafd47accff2ea5c8de20 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-04 | 190 | 130 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-APOE+_Mac1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.44e-04 | 191 | 130 | 5 | c204ec71b7755b46a18d3a6aa84d0f407145ce9d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.44e-04 | 191 | 130 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-04 | 192 | 130 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.50e-04 | 192 | 130 | 5 | 935a4a36881a9fa4daa02cba96af07f6686ed8d6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-04 | 192 | 130 | 5 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.50e-04 | 192 | 130 | 5 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-04 | 193 | 130 | 5 | 837c61408462c519912ecf3b83fdc72cd85fe88f | |
| ToppCell | Control-Myeloid-MoAM3|Control / Disease group,lineage and cell class (2021.01.30) | 2.56e-04 | 193 | 130 | 5 | 97d2f12be43fc26efa84ac4c6119132928a123de | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 193 | 130 | 5 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-04 | 193 | 130 | 5 | 7fc3ab7261c88c1df71744bf5b17e8e46c4300e0 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-04 | 193 | 130 | 5 | d81840e1322507552b7726bf7828309375162324 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.56e-04 | 193 | 130 | 5 | e4ca3a3c2704cdc52e6ac3f25f14debf74226c29 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-04 | 193 | 130 | 5 | b52d5661edff83ac4c5fe2bf89d6672016bb827b | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.56e-04 | 193 | 130 | 5 | e54f8b6381b5a96758cff41ab12d6f60cfca29a9 | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.62e-04 | 194 | 130 | 5 | a4523adbbd25c314809eed3414d66a5b323446e5 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.62e-04 | 194 | 130 | 5 | 094e8dfe640c7cca410b85f93063ea0bd7e861cf | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.62e-04 | 194 | 130 | 5 | 245a3eb6db9c862b73ad34a8cd2898a3688c16f6 | |
| ToppCell | erythropoietic-CD34+_Pro-erythroblast|World / Lineage and Cell class | 2.62e-04 | 194 | 130 | 5 | cd12d01f6f2f12bbc33ed523bc678d3965074974 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 194 | 130 | 5 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.62e-04 | 194 | 130 | 5 | 125bf2909cf89133693bc7b865ca08955cf67a2e | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 194 | 130 | 5 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.60e-06 | 193 | 129 | 9 | 5584_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A | 1.41e-05 | 192 | 129 | 8 | 2703_DN | |
| Drug | 8-bromoguanosine | 1.50e-05 | 93 | 129 | 6 | CID000092977 | |
| Drug | lomustine; Down 200; 100uM; MCF7; HT_HG-U133A | 1.52e-05 | 194 | 129 | 8 | 7089_DN | |
| Drug | Thiostrepton [1393-48-2]; Down 200; 2.4uM; MCF7; HT_HG-U133A | 1.58e-05 | 195 | 129 | 8 | 2823_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.64e-05 | 196 | 129 | 8 | 4956_DN | |
| Drug | Myosmine [532-12-7]; Down 200; 27.4uM; MCF7; HT_HG-U133A | 1.76e-05 | 198 | 129 | 8 | 4759_DN | |
| Drug | Thiethylperazine malate [52239-63-1]; Down 200; 6uM; HL60; HT_HG-U133A | 1.83e-05 | 199 | 129 | 8 | 6154_DN | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.89e-05 | 200 | 129 | 8 | 6628_DN | |
| Disease | epilepsy (implicated_via_orthology) | 6.04e-06 | 163 | 124 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Abruptio Placentae | 5.24e-05 | 3 | 124 | 2 | C0000832 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 6.68e-05 | 19 | 124 | 3 | DOID:1168 (biomarker_via_orthology) | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 6.68e-05 | 19 | 124 | 3 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 6.68e-05 | 19 | 124 | 3 | C2936783 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.74e-04 | 5 | 124 | 2 | C3281201 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.75e-04 | 26 | 124 | 3 | C0009405 | |
| Disease | angina pectoris | 1.90e-04 | 125 | 124 | 5 | EFO_0003913 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 1.97e-04 | 27 | 124 | 3 | C1112155 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 2.44e-04 | 29 | 124 | 3 | C1333990 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 6.19e-04 | 9 | 124 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | total lipids in lipoprotein particles measurement | 1.09e-03 | 48 | 124 | 3 | EFO_0022309 | |
| Disease | right ventricular stroke volume measurement | 1.12e-03 | 12 | 124 | 2 | EFO_0021817 | |
| Disease | eosinophil measurement | 1.14e-03 | 108 | 124 | 4 | EFO_0803540 | |
| Disease | coronary artery disease, factor VII measurement | 1.26e-03 | 111 | 124 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | cardiomyopathy (biomarker_via_orthology) | 1.33e-03 | 13 | 124 | 2 | DOID:0050700 (biomarker_via_orthology) | |
| Disease | Coffin-Siris syndrome | 1.33e-03 | 13 | 124 | 2 | C0265338 | |
| Disease | factor VIII measurement, coronary artery disease | 1.34e-03 | 113 | 124 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.43e-03 | 195 | 124 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | factor XI measurement, coronary artery disease | 1.43e-03 | 115 | 124 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.54e-03 | 14 | 124 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | coronary artery disease | ABCA1 DYNC2H1 USP43 AS3MT EPG5 IGSF10 LOXL1 OR52E4 SMARCA4 PLCG1 DOCK6 NOS3 PHACTR1 | 1.57e-03 | 1194 | 124 | 13 | EFO_0001645 |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.58e-03 | 118 | 124 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 1.62e-03 | 55 | 124 | 3 | EFO_0022288 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 2.29e-03 | 17 | 124 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 2.29e-03 | 17 | 124 | 2 | OBA_2045173 | |
| Disease | essential hypertension (is_implicated_in) | 2.56e-03 | 18 | 124 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | phospholipid measurement | 2.93e-03 | 140 | 124 | 4 | EFO_0004639 | |
| Disease | stroke, coronary artery disease | 3.49e-03 | 21 | 124 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | myocardial infarction | 3.69e-03 | 350 | 124 | 6 | EFO_0000612 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.70e-03 | 243 | 124 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | Bipolar Disorder | 4.11e-03 | 477 | 124 | 7 | C0005586 | |
| Disease | fibrinogen measurement, coronary artery disease | 4.12e-03 | 154 | 124 | 4 | EFO_0001645, EFO_0004623 | |
| Disease | primary open angle glaucoma (is_implicated_in) | 4.18e-03 | 23 | 124 | 2 | DOID:1070 (is_implicated_in) | |
| Disease | Immunologic Deficiency Syndromes | 4.18e-03 | 23 | 124 | 2 | C0021051 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKFVQSSGRIRQPSV | 1006 | Q5SW79 | |
| GFGRKSPLSNRFRVV | 2471 | Q9HCE0 | |
| FKNSRFFPGRIRRVI | 921 | P04920 | |
| TNRPKGFTRFRSAVR | 3756 | Q99996 | |
| GVFESRRKNKAVFRP | 361 | Q96N23 | |
| FRNRPDFRKNKGRQL | 161 | A6NEN9 | |
| FNKRILCLFRPQSGR | 111 | O43598 | |
| TREPRAQKEQRFGFR | 231 | O94812 | |
| RFQQFIRKVTRPAVL | 361 | Q92974 | |
| RRQQQAPKSAFPRLF | 306 | Q5MAI5 | |
| KAVSRSQRAGLQFPV | 16 | Q71UI9 | |
| RRSRKGFFAQIVLPA | 1341 | O95477 | |
| VGNRFQQKLRSVFRV | 321 | P50052 | |
| IPQFTLANRTQGRRF | 376 | Q8WV93 | |
| GLVQRFRPDFKRKFA | 216 | Q8TB40 | |
| PRQQPSALFARGNRK | 151 | Q6IQ19 | |
| RPDFGQIKGFIRRFN | 776 | P20594 | |
| RVTFKANRPFLVFIR | 431 | P01008 | |
| LRRNVGFQVRLESKP | 511 | Q7L2E3 | |
| QPAVLRGARVFLRQK | 1901 | Q00975 | |
| RGNLRQAAIDRFSKP | 1341 | Q9P2D1 | |
| ASRASRLNLFFQGKP | 21 | O14578 | |
| RARKIQRFLSQPFQV | 456 | P06576 | |
| AARNFGFVFRSRTPK | 521 | P98198 | |
| FRRVRINFSNPKSAA | 51 | Q14206 | |
| RAVRQVFQRAKNSAP | 661 | O15381 | |
| PAFQQRLRLGAKRAV | 146 | Q8WYB5 | |
| RFRVNKLPRFLGSDN | 231 | Q6IWH7 | |
| PQKVNFVLSSNRGRR | 686 | Q9NRD9 | |
| QKANLRIRFRPSLFQ | 346 | Q9UM21 | |
| VFRLPSQDVRLKAFN | 226 | Q8NGH9 | |
| PVFLNSRGLSNARKF | 841 | Q9ULH0 | |
| IQVARFRAKFDPRVL | 46 | Q96QS6 | |
| GRKGLPRSFLNRFTQ | 1876 | Q9NU22 | |
| NPRLNIKAFVRNSFL | 231 | O00214 | |
| KPEGLFRNRFEVRNA | 146 | O75648 | |
| LKFSFLRGQRQPSVT | 471 | Q5JYT7 | |
| PFLQFRRNVFFPKRR | 121 | Q9BZ67 | |
| RFPQRVKNQGTADFL | 421 | Q08397 | |
| FLPKQRRTGLFSATQ | 191 | Q8NHQ9 | |
| AFARRDFRKGSPQLV | 21 | Q9BXJ5 | |
| FVKQRRGVISPNFSF | 286 | Q05923 | |
| GVPILASFLRKNQRA | 651 | Q86VP6 | |
| QKTQGLRRFAFPLSL | 216 | Q13144 | |
| RTQAEFPLRALQFKR | 51 | Q8IZT8 | |
| AGLRVFRNQLPRKND | 91 | Q16342 | |
| LGLPNRLRFFRQSVA | 61 | Q9BXM7 | |
| FFDTQKTRQRGGRPR | 376 | A6H8Z2 | |
| AGRSFQIFRALKQPL | 1826 | O94915 | |
| LVGPFLQRFQQERTR | 1251 | Q9ULK4 | |
| KRQQFGSRFLSDPAR | 16 | Q6P1Q9 | |
| KSQELRSGPRRQLNF | 86 | Q5T7B8 | |
| PQVRIRKNTLGFFIA | 576 | A8MYU2 | |
| FRGPKNGRFALVDQR | 251 | Q9P215 | |
| DRRFRPFQFGSAKVL | 421 | Q96RP7 | |
| KSFRFTPRVQRLNEL | 66 | P29375 | |
| KGQQASPFVLRARRS | 61 | Q9BUE0 | |
| KRQQFGSRFLRDPAR | 16 | Q96IZ6 | |
| QQLGRLFRKAFDPRV | 536 | P29474 | |
| PIRRRSKFANLGRIF | 106 | Q9C0D0 | |
| EFRDKVRAGLFQRSP | 346 | Q96RI0 | |
| KGVDTFLRRPNFTRA | 231 | Q86YC2 | |
| RTLVNGFAKNPLQAR | 46 | Q8NHR9 | |
| TRNSRFFNIAKDPRV | 76 | O94856 | |
| FGRGALPKEQTRFNR | 1356 | Q8NCM8 | |
| GSIKEFRNRFINPIQ | 1771 | P46100 | |
| TVNIPLFRRFGRQRK | 1001 | Q6WRI0 | |
| RKVRFSFEQPDGRAQ | 371 | P29466 | |
| PGLRNSLNRASFRKA | 2031 | Q96HP0 | |
| TRDLAGLRQFFKQLP | 241 | P49716 | |
| RKLNSRLFVVRGQPA | 86 | Q49AN0 | |
| RGLQGRKLVAPFRFE | 201 | O95727 | |
| PSQRGFLQRRSKFSR | 296 | Q68DX3 | |
| QAIARRLKPFGVQRF | 166 | Q9UBQ7 | |
| KNSRFAQDFLIRPIG | 311 | Q9HBK9 | |
| NPRPIVKITERFFRN | 581 | Q8IY82 | |
| APRFRHRGKVIAFQL | 451 | O75578 | |
| KAVSRSQRAGLQFPV | 16 | P0C0S5 | |
| RKARPRQFPFLASIQ | 31 | P20160 | |
| VDPRRPFRKLNAFGN | 116 | Q9H4M9 | |
| RRLSAFQQGFFRNKI | 951 | P20648 | |
| FNRLVPSVNGVRRFS | 476 | P11586 | |
| AVRVRPFSQREKNSG | 11 | B7ZC32 | |
| FPNLARVLQRRFSGL | 171 | Q9BTL4 | |
| AFALNRRNLPGDRAK | 356 | Q99683 | |
| RKFLQRFLREGPNKT | 46 | Q9BV86 | |
| NSISFPRFKVNRRNL | 191 | P51575 | |
| QVLRNGTKVVRSFRP | 166 | Q92777 | |
| FQLRQLPVVKFRRTG | 6 | Q8N4V2 | |
| ARLGLRPVKQVRVQF | 6 | Q96EL3 | |
| RRSLVPQLRSGKFNV | 811 | P51531 | |
| QAAPKGREAFRSQRR | 26 | Q9ULQ0 | |
| FKRTRITGNPVVTNR | 256 | Q9HCE1 | |
| NPRFEAPLFNARIRK | 406 | P28331 | |
| AFRKALLNPVTSRQF | 1021 | Q8NE09 | |
| RPFVLARAFFAGSQR | 596 | Q14697 | |
| LRPETAQGIFLNFKR | 296 | P41250 | |
| VGRLQDPQKVARFQR | 11 | Q9BX95 | |
| RRAFVPQLRSGKFNV | 841 | P51532 | |
| GAFPAAQVQRRRVKK | 161 | Q96JF0 | |
| FRLFKRRQGRIFPEG | 246 | Q9UIB8 | |
| LPQKFIFQSERGRFI | 956 | Q6P9B9 | |
| FKRAIANGQRALPRD | 141 | O75783 | |
| IFNKPECGRVQRAIF | 831 | Q9UQ84 | |
| QTFVGRALQPVKVFR | 1096 | P63128 | |
| SQLVARFQRRCGLFP | 11 | Q8IWX5 | |
| NPIRSKIVRAFFDNR | 56 | Q96BS2 | |
| NASFFKQLSLGRPRR | 11 | A8K5M9 | |
| KAEFRVFRLQNPKAR | 146 | P61812 | |
| PVRQRLGNFSRAVFS | 6 | Q86X19 | |
| FARKRQEAVAGRIPA | 361 | Q12933 | |
| SFKERLARSRPQFRG | 101 | Q15170 | |
| FPSKSQRFLRVGLAV | 286 | Q70EL4 | |
| VGNAARPRFERNKLL | 11 | P23510 | |
| APKFRKVAAQRLRGF | 511 | Q9BRG2 | |
| GAPRAERFEKFQRVL | 551 | Q9BRG2 | |
| AVQFIRQKRRGAFNS | 126 | Q12974 | |
| SLFSKIRRGQFNIPE | 261 | Q92519 | |
| UKLGRFPQVQAFVRS | 96 | O60613 | |
| KSFLQRVNASPAGRR | 151 | Q8N554 | |
| RPEGKNNRLFVFSIS | 886 | P19174 | |
| IRKVFRAAAAQFQVP | 331 | Q6XQN6 | |
| RQQPATEKRGSIVRF | 2026 | Q68DE3 | |
| FLRFIRARKFNVGRA | 96 | P12271 | |
| PFIRRQIFRSIKVFT | 711 | Q9BY31 | |
| QIFRSIKVFTRGRNP | 716 | Q9BY31 | |
| LNGAAIFFPNRQTRR | 861 | O43149 | |
| QTFVGRALQPVREKF | 176 | Q9WJR5 | |
| KRQPGENRVTLIFFL | 536 | Q96AX1 | |
| NRRVGNTLKPFSRVL | 241 | P0DMS9 | |
| PGFRRQASLSQSIRK | 106 | Q6PJF5 | |
| LRLQQVSRPTFFARK | 491 | Q9H1B5 | |
| RNGGKNFPAIFRRIQ | 246 | Q9UBP6 | |
| IRGFLVRKNLSPVFF | 226 | A6PVS8 |